Female Sling Procedure

September 27, 2020 updated by: Ahmed Maher Gamil Ahmed Higazy, Ain Shams University

A Two Paramedian Vaginal Incisions Versus the Standard Longitudinal Incision of Trans-Obturator Tape Procedure for Management of Urinary Incontinence

In trans-obturator tape (TOT), tension and location of the tape in mid urethral zone are directly related to the postoperative clinical outcome. Recurrence of symptoms of stress urinary incontinence has been related to tape migration in previous studies. The study aimed to increase the success rate of TOT procedure through a new surgical technique using a 2 paramedian vaginal incisions.

Study Overview

Status

Completed

Detailed Description

the investigator innovated a new technique that involves a 2 paramedian vaginal incisions that allow more tape stabilization with sparing the dissection along the whole urethra ensuring intact overlying tissues and to create a tunnel in between the 2 incisions to pass the tape, making it supported proximally and distally with normal undissected tissues.

the study aims to assess the success rate of TOT and tape migration using a new surgical technique versus the standard procedure using vertical incision.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Phase 2
  • Phase 3

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • adult female patient complaining of pure stress incontinence confirmed by stress test of urodynamic study

Exclusion Criteria:

  • Patients with neurological disease, pelvic organ prolapse, previous urethral or pelvic floor surgery will be excluded from our study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: the classical TOT procedure
performing the trans-obturator procedure through the standard vertical incision
TOT procedure will be done using silicon-coated polypropylene tape that will be inserted at the mid-urethral portion. In group 1, a classical vertical vaginal incision will be done proximal to the external urethral meatus with dissection along the axis of the urethra till the mid-urethral zone that is identified by palpating the urethral catheter balloon through the vaginal at the bladder neck, while in group 2, two paramedian incisions will be done 1cm long in the anterior vaginal wall 2 cm apart parallel to the urethra till identification of the mid-urethral portion, communication will be done between the two incisions 1 cm wide in this area creating a tunnel where the tape will be placed, this technique provides healthy tissues proximal and distal to the tape that allows more stabilization and less migration. The rest of the procedure is the same as the standard procedure of Trans-obturator outside-in tension-free technique.
Experimental: 2 paramedian vertical incisions
performing the trans-obturator procedure through a new technique of 2 paramedian vertical incisions
TOT procedure will be done using silicon-coated polypropylene tape that will be inserted at the mid-urethral portion. In group 1, a classical vertical vaginal incision will be done proximal to the external urethral meatus with dissection along the axis of the urethra till the mid-urethral zone that is identified by palpating the urethral catheter balloon through the vaginal at the bladder neck, while in group 2, two paramedian incisions will be done 1cm long in the anterior vaginal wall 2 cm apart parallel to the urethra till identification of the mid-urethral portion, communication will be done between the two incisions 1 cm wide in this area creating a tunnel where the tape will be placed, this technique provides healthy tissues proximal and distal to the tape that allows more stabilization and less migration. The rest of the procedure is the same as the standard procedure of Trans-obturator outside-in tension-free technique.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
tape migration
Time Frame: to be evaluated at 3rd month postoperative
to evaluate TOT migration postoperative from the middle third of the urethra by trans-labial ultrasound
to be evaluated at 3rd month postoperative
tape migration
Time Frame: to be evaluated at 6th month postoperative
to evaluate TOT migration postoperative from the middle third of the urethra by trans-labial ultrasound
to be evaluated at 6th month postoperative
tape migration
Time Frame: to be evaluated at12th month postoperative
to evaluate TOT migration postoperative from the middle third of the urethra by trans-labial ultrasound
to be evaluated at12th month postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
continence after surgery
Time Frame: to be evaluated at 3,6 and 12 month postoperative
to evaluate success rate in treatment of stress urinary incontinence using stress cough test and urodynamic study
to be evaluated at 3,6 and 12 month postoperative
de-novo urgency
Time Frame: to be evaluated at 12 month postoperative
appearance of urgency incontinence from patient symptomology evaluation whether present or not
to be evaluated at 12 month postoperative
vaginal erosion
Time Frame: to be evaluated up to 1 year post operative
postoperative complication of TOT where vagina erosion may occur, (yes/no)
to be evaluated up to 1 year post operative
urine retention
Time Frame: to be evaluated in the first 24 hours postoperative
postoperative complication of TOT ( present or not)
to be evaluated in the first 24 hours postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2016

Primary Completion (Actual)

February 1, 2018

Study Completion (Actual)

February 1, 2018

Study Registration Dates

First Submitted

September 19, 2020

First Submitted That Met QC Criteria

September 27, 2020

First Posted (Actual)

October 1, 2020

Study Record Updates

Last Update Posted (Actual)

October 1, 2020

Last Update Submitted That Met QC Criteria

September 27, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Urinary Incontinence,Stress

Clinical Trials on trans-obturator procedure

3
Subscribe